Interestingly, in vitro observations showed that sitagliptin sensitizes CRC cells to 5-Fluorouracil (5-FU) by decreasing the expression of MDR1 mRNA and the p-AKT and NFκB2 subunits p100/p52 proteins [43]. The gene discussed is NFKB2; the disease is colorectal carcinoma.